The 'Wearing Off' Effect of DMT

Condition:   Multiple Sclerosis Interventions:   Other: ocrelizumab;   Other: natalizumab;   Other: ofatumumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - November 25, 2022 Category: Research Source Type: clinical trials